These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10505737)

  • 1. Cholylsarcosine for bile acid deficiency caused by ileal resection.
    Popović OS; Jojić N; Necić D
    Dig Dis Sci; 1999 Sep; 44(9):1931-2. PubMed ID: 10505737
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.
    Longmire-Cook SJ; Lillienau J; Kim YS; Schteingart CD; Danzinger RG; Esch O; Hofmann AF
    Dig Dis Sci; 1992 Aug; 37(8):1217-27. PubMed ID: 1379904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.
    Lillienau J; Schteingart CD; Hofmann AF
    J Clin Invest; 1992 Feb; 89(2):420-31. PubMed ID: 1371123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.
    Kapral C; Wewalka F; Praxmarer V; Lenz K; Hofmann AF
    Z Gastroenterol; 2004 Jul; 42(7):583-9. PubMed ID: 15248106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholysarkosin in treatment of bile acid deficiency syndrome].
    Weinand I; Stein J
    Z Gastroenterol; 1999 Jul; 37(7):675-7. PubMed ID: 10458016
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.
    Schmassmann A; Fehr HF; Locher J; Lillienau J; Schteingart CD; Rossi SS; Hofmann AF
    Gastroenterology; 1993 Apr; 104(4):1171-81. PubMed ID: 7681796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.
    Heydorn S; Jeppesen PB; Mortensen PB
    Scand J Gastroenterol; 1999 Aug; 34(8):818-23. PubMed ID: 10499484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
    Ricci P; Hofmann AF; Hagey LR; Jorgensen RA; Rolland Dickson E; Lindor KD
    Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
    Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
    Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation.
    Schmassmann A; Angellotti MA; Ton-Nu HT; Schteingart CD; Marcus SN; Rossi SS; Hofmann AF
    Gastroenterology; 1990 Jan; 98(1):163-74. PubMed ID: 1688373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs.
    Frisch K; Jakobsen S; Sørensen M; Munk OL; Alstrup AK; Ott P; Hofmann AF; Keiding S
    J Nucl Med; 2012 May; 53(5):772-8. PubMed ID: 22454486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated bile acid replacement therapy for short-bowel syndrome.
    Gruy-Kapral C; Little KH; Fordtran JS; Meziere TL; Hagey LR; Hofmann AF
    Gastroenterology; 1999 Jan; 116(1):15-21. PubMed ID: 9869597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome.
    Fürst T; Bott C; Stein J; Dressman JB
    J Pharm Pharmacol; 2005 Jan; 57(1):53-60. PubMed ID: 15638993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
    Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
    Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.
    Chen X; Chen F; Liu S; Glaeser H; Dawson PA; Hofmann AF; Kim RB; Shneider BL; Pang KS
    Mol Pharmacol; 2006 Jun; 69(6):1913-23. PubMed ID: 16481392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in bile salt composition after cholecystectomy and ileal resection.
    Stein TA; Nilsson LO; Burns GP; Mandell C; Wise L
    Am J Surg; 1985 Sep; 150(3):361-4. PubMed ID: 4037197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile-salt deficiency in the steatorrhea following resection of the ileum and proximal colon.
    Hardison WG; Rosenberg IH
    N Engl J Med; 1967 Aug; 277(7):337-42. PubMed ID: 4378268
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats.
    Heuman DM; Vlahcevic ZR; Pandak WM; Hylemon PB; Kim YS; Lillienau J; Hofmann AF
    Gastroenterology; 1992 Nov; 103(5):1641-8. PubMed ID: 1385253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine.
    Michael S; Thöle M; Dillmann R; Fahr A; Drewe J; Fricker G
    Eur J Pharm Sci; 2000 Apr; 10(2):133-40. PubMed ID: 10727879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterohepatic circulation of bile acids in infants and children with ileal resection.
    Heubi JE; Balistreri WF; Partin JC; Schubert WK; Suchy FJ
    J Lab Clin Med; 1980 Feb; 95(2):231-40. PubMed ID: 7354235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.